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ABSTRACT
l-Red system-based recombinogenic engineering
is a powerful new method to engineer DNA without
the need for restriction enzymes or ligases. Here,
we report the use of a single selectable marker to
enhance theusefulness of thisapproach.Thestrategy
is to utilize the thymidylate synthase A (thyA) gene,
which encodes an enzyme involved in the synthesis
of thymidine 50-triphosphate, for both positive and
negative selection. With this approach, we success-
fully created point mutations in plasmid and bacterial
artificial chromosome (BAC) DNA containing the
mouse Col10a1 gene. The results showed that the
thyA selection system is highly efficient and accurate,
giving an average of .90% selection efficiency. This
selection system produces DNA that is free from
permanent integration of unwanted sequences,
thus allowing unlimited rounds of modifications if
required.
INTRODUCTION
Recent advances in homologous recombination-based DNA
engineering technology, termed recombinogenic engineering
or recombineering, have led to the development of highly
efficient procedures with which chromosomal or plasmid
DNA can be modified in Escherichia coli by the introduction
of mutations, such as single base substitutions, deletions and
insertions. These methods are based upon the rac-encoded
RecET system or the bacteriophage l-Red recombination
system (1–6), eliminating the need for in vitro manipulations
using restriction enzymes or DNA ligases (7,8). The three
proteins of the Red system, Exo, Beta and Gam, mediate
recombination between a linear double-stranded DNA
donor and its homologous target sequence by promoting
double-strand break repair (9–15).
This system, while powerful, suffers from a relatively low
rate of recombination events, so that screening of a large
number of bacterial colonies is still required in most cases.
This limitation can be overcome by incorporating a selectable
marker to assist in selection of the desired recombinants.
Selection protocols generally use antibiotic resistance genes
flanked by loxP or frt sites, such that the selectable marker can
later be removed by cre- or flp-mediated recombination (10).
This method is highly efficient but unavoidably leaves at least
one loxP or frt sequence behind. Alternatives include antibi-
otic-sacB cassettes, such as SacB–neo, which have been used
in a two-step modification procedure to avoid unwanted
residual DNA (4,16,17). In the first round of recombination,
cells are transformed with the sacB–neo fusion cassette and
are selected for their resistance to kanamycin. Subsequently,
an appropriate DNA cassette is introduced to replace the entire
sacB–neo cassette to create the desired change in DNA
sequence. Cells retaining the sacB marker gene will not sur-
vive in 7% sucrose. However, these methods can result in
unwanted rearrangement (18) and require labor-intensive
screening procedures to distinguish clones with the desired
recombineered product from cells that survived owing to
mutational events that prevented the expression of the
counter-selectable gene.
Here, we describe a novel selection approach in E.coli
utilizing the l-Red recombineering system. It is a single
selectable marker approach with selection criteria based on
previous work performed in Bacillus subtilis (9,19). In
brief, the selectable marker is the enzyme encoded by the
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thymidylate synthase A (thyA) gene, which is involved in the
de novo synthesis of dTTP from dUMP. Without thyA, the cell
is unable to synthesize DNA and, therefore, will not grow in
minimum growth media. Thus, in a thyA-null E.coli mutant
(DthyA), recombinants containing an exogenous thyA gene can
be selected for (positive selection) by culture in growth
medium in the absence of thymine. When thymine is provided,
de novo dTTP synthesis can proceed without the need for
ThyA function.
The activity of ThyA requires the cofactor tetrahydrofolate
(THF), which is converted to dihydrofolate (DHF) in the pro-
cess. THF is also an important cofactor for many other essen-
tial cellular reactions and is replenished from DHF by the
action of dihydrofolate reductase, which can be inhibited by
trimethoprim. Thus, recombination events in which the thyA
gene is removed can then be selected for (negative selection)
using growth media containing thymine and trimethoprim.
Under these culture conditions, cells with functional thyA
exhaust the supply of THF then growth is supressed because
it cannot be replenished in the presence of trimethoprim. In
cells lacking a functional thyA gene, sufficient THF is main-
tained for other cellular reactions and dTTP can be synthesized
from thymine; thus, these cells will grow.
We have generated a thyA-null E.coli deletion strain
harboring a defective lambda prophage, which contains the
three Red genes with their expression tightly controlled by a
temperature-sensitive repressor. Red induction occurs when
the temperature is switched from the normal 32 to 42C. At
the higher temperature, the repressor comes off, allowing the
expression of Exo, Bet and Gam. We have also established
culture conditions for both positive and negative selection
when an exogenous thyA gene is re-introduced and
subsequently removed. The strategy is that using this strain
of E.coli as a host, a thyA gene with its promoter can be
introduced anywhere in a plasmid or bacterial artificial chro-
mosomes (BACs) DNA sequence specifically by homologous
recombination, and this event is selected for using positive
selection. Subsequently, point mutations, deletions or inser-
tions can be introduced precisely in the plasmid or BAC DNA
through the removal of the thyA gene, again by homologous
recombination, and this event is selected for using positive
selection for growth in the absence of ThyA. In a proof of
principle experiment, point mutations were introduced into the
mouse collagen X gene (Col10a1) in plasmid and BAC DNA
with selection efficiency >90%.
MATERIALS AND METHODS
Bacterial strains and growth media
Two bacterial strains, DY380 and QW1, were used in this
study. DY380 is a gift from Dr Don Court (10) and is a
modification of DH10B [F mcrA D(mrr-hsdRMS-mcrBC)
f80dlacZDM15 DlacX74 deoR recA1 endA1 araD139
D(ara, leu) 7649 galU galK rpsL nupG] that includes the
Red genes [lcI857 (cro-bioA) <> tet] as a prophage. QW1
is a further modification of DY380 created in the current study
with the thyA gene deleted [DthyA].
Cells were grown in a modified M9 minimal medium
(48 mM Na2HPO4.7H2O, 22 mM KH2PO4, 8.6 mM NaCl
and 18.7 mM NH4Cl), containing 1 mM MgSO4, 0.5 mM
CaCl2, 0.4% (w/v) glucose, 0.6 mM leucine, valine and iso-
leucine, 30 nM vitamin B1, 1% (v/v) Luria–Bertani (LB) broth
and 1· MM1 containing 1 nM each of ZnSO4, CuSO4,
Na2MoO4, CoCl2, MnSO4, CrCl3, NiCl2. Specific growth
selection medium was supplemented with either or combina-
tion of 50 mg/ml ampicillin, 12.5 mg/ml chloramphenicol, 0.79
mM thymine (Sigma) and 10 mg/ml (for plasmids) or 20 mg/ml
(for BACs) trimethoprim (Sigma). For growth on agar plates,
2.5% (w/v) noble agar (Sigma) was included in the appropriate
medium. All chemicals were of analytical grade.
Polymerase chain reaction
PCR was used for the amplification of DNA fragments with
the GeneAmp PCR System 9700 (Applied Biosystems). The
high-fidelity Pfx DNA polymerase (Invitrogen) was used in
all the reactions, prepared as specified by the supplier. The
general condition included an initial denaturation at 94C for
5 min, followed by 30 cycles of denaturation at 94C for 45 s,
annealing at 55C for 45 s and extension at 72C for 45 s to
1 min 30 s, depending on the length of the DNA to be amp-
lified. PCR products were gel-purified and recovered using the
gel purification kit from Qiagen. The quality and concentration
of DNA were analyzed by gel electrophoresis and UV spec-
trophotometry, respectively.
Preparation of DNA fragment for recombineering
procedures
All linear DNA fragments were generated by PCR amplifica-
tion and the appropriate primers are shown in Table 1. Primers
thyAF1 and thyAR1 were used to amplify a 1470 bp DNA
fragment (Figure 2A) containing the full-length thyA gene
(thyA-FL) using DY380 chromosomal DNA as template.
The amplified DNA was cloned into pBluescript KS II (+)
(Stratagene) to generate the plasmid, pThyA-FL.
A 744 bp DNA fragment (Figure 2A) containing a truncated
‘inactive’ version of the thyA gene (DthyA) was generated by
overlapping PCR using pThyA-FL plasmid DNA as a tem-
plate. The primers used to generate the two overlapping frag-
ments were thyAF1 and thyAR2, and thyAF2 and thyAR1
(Table 1). The resultant amplification fragments were purified
and used as templates in the second round of overlapping PCR
with primers thyAF1 and thyAR1. In Table 1, the nucleotides
in bold represent the overlapping regions where the two frag-
ments will anneal to one another.
A 1124 bp DNA fragment (Figure 2A) containing an ‘act-
ive’ version of the thyA gene lacking a small region 30 of the
translation stop and terminator of the thyA gene (thyAD30) was
amplified using primers thyAF1 and thyAR3 (Table 1) with
plasmid pThyA-FL as a template. This fragment was cloned
into pBluescript KS II (+) to generate the plasmid, pThyA-D30.
For site-directed mutagenesis in a plasmid containing the
mouse collagen X gene (Col10a1), two PCR-amplified DNA
fragments were generated, X-thyAD30-X0 and ColX-G18D.
The X-thyAD30-X0 fragment was amplified using pThyA-
D30 plasmid DNA as template and primers ColX-thyAF and
ColX-thyAR (Table 1). The highlighted nucleotides in the
primers are nucleotide sequence of Col10a1 flanking the
site of mutagenesis. The ColX-G18D fragment was generated
by overlapping PCR (Figure 2B) as described below and in
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previous mutagenesis of the human COL10A1 gene (20). In
brief, two overlapping DNA fragments were generated using
primers ColX-F and ColX-mR, ColX-mF and ColX-R. The
overlap fragment contained a 2 bp substitution changing the
codon GGG for glycine at residue 18 (relative to the start of
translation) to GAT for aspartate in the precollagen X a-chain,
analogous to a mutation in the signal peptide cleavage
site (21).
For site-directed mutagenesis in a Col10a1 containing
BAC, primers (ColX-F and ColX-R) were used to amplify
a 566 bp PCR fragment from a plasmid (pG18D-Flag) con-
taining a different variant of the G18D mutation (GGG to
GAC) and an in-frame insertion of the Flag1 sequence
(50-GACGACGATGACAAGCTTGCGGGCCCA-30) at the
30 region of exon 2 (Figure 2C).
Electroporation of DNA into bacterial cells
Appropriate bacterial cells were prepared for electroporation
as described previously. The Red gene functions were induced
at 42C for 15 min to allow the expression of Exo, Bet and
Gam as the temperature-sensitive repressor falls off at this
high temperature. Cells grown at 32C without induction
were used as a control (5). In brief, 50 ml of ‘competent’
cells were mixed with 2–8 mg of the PCR-amplified DNA
in a pre-cooled 0.1 cm Gene Pulser cuvette (Bio-Rad Labor-
atories) and electroporated using the Bio-Rad Gene Pulser
with conditions set at 1.8 kV, 25 mF and 200 ohms. Following
electroporation, the cells were grown in 1 ml of LB broth at
32C for 1–1.5 h, collected by centrifugation and plated at
various dilutions onto M9 minimal medium agar plates with
appropriate supplements for selective growth, and incubated at
32C for 48–72 h.
Generation of a thyA-null bacterial strain (QW1)
The thyA-null strain (QW1) was constructed by electroporat-
ing the 744 bp ‘inactive’ DthyA DNA fragment (created by
overlapping PCR as described above) into DY380 following
activation of the l-Red recombinase system. Clones with
the appropriate homologous recombination event inactivat-
ing the endogenous thyA gene were selected for culturing
electroporated cells on modified M9 minimal growth agar
plates supplemented with 0.79 mM thymine and 10 mg/ml
trimethoprim.
Mutagenesis of the mouse Col10a1 gene
A plasmid, pKM2-ColX, containing 10 kb of the mouse
Col10a1 gene was first transformed into QW1. Next, 4 mg
of X-thyAD30-X0 DNA fragment (constructed as described
above) was electroporated into ‘competent’ QW1 cells har-
boring pKM2-ColX. Appropriate clones with a functional
thyA gene were selected by growth on modified M9 minimal
growth media agar in the absence of thymine. Clones (QW1-
pKM2-ColX-ThyA) that grew under these conditions had a
functional thyA gene introduced into pKM2-ColX at the
desired location by homologous recombination. Subsequently,
4 mg of ColX-G18D DNA (generated as described above) were
electroporated into ‘competent’ cells derived from a QW1-
pKM2-ColX-ThyA clone. Cells were then grown on modified
M9 minimal agar plates supplemented with 0.79 mM thymine
and 10 mg/ml trimethoprim to select for the absence of thyA
gene function.
Similar procedures were carried out for mutagenesis in a
319 kb BAC (RP23-194I3, accession no. AC021709.12)
containing the mouse Col10a1 gene, except that in the final
mutagenesis step, between 2 and 8 mg of a PCR product,
FColX-G18D (Figure 2C) was electroporated into ‘competent’
cells derived from QW1 containing the RP23-194I3 BAC
with thyA introduced at the appropriate site for subsequent
mutagenesis.
RESULTS
Generation of a thyA-null bacterial strain (QW1)
Utilizing the l-Red recombination function present in DY380,
the thyA gene was inactivated through homologous recomb-
ination between DY380 chromosomal DNA and a PCR-
amplified DNA fragment, DthyA. The overall strategy is
outlined in Figure 1A. Growth selection for the absence of
ThyA function resulted in >250 colonies when the l-Red
Table 1. Normal and mutant primers for PCR site-directed mutagenesis
Primers Primer sequence (50 to 30) Position Orientation
thyA-F1 GCTGCTGCTGGAAGGTGTGGT 277 to 257 Forward
thyA-R1 CCCTCCCTGATAACGCTGATA +1193 to +1173 Reverse
thyA-F2 GTTTTAACCTGCAAGATGGCCGTTAAATTCTTCGAGACGC +104 to +122::+849 to +869 Forward
thyA-R2 GCGTCTCGAAGAATTTAACGGCCATCTTGCAGGTTAAAAC +869 to +849::+122 to +104 Reverse
thyA-R3 GGGTAAAAAAACCGACGCACAC +847 to +826 Reverse
ColXF CAAGGCAGTTTCCAAACACTAG 223 to 202 Forward
ColXR CCATGCATCATTCCGCTGTAC +307 to +287 Reverse
ColX-thyAF TTCTCTTCTGCTTTTCAGAATCTATCTGAAAATATGCTG
CCTCAAATACCGCTGCTGCTGGAAGGTGTGGTCGTC
33 to +17::277 to 253 Forward
ColX-thyAR ACCTTTACTCTTTATGGCGTATGGGATGAAGTATTGTGT
CTTGGGGCTAGGGGTAAAAAAACCGACGCACACTGGCG
+156 to +107::+847 to +820 Reverse
ColX-mR TATCATGAACCAGGGTCAAGAAC +55 to +33 Reverse
ColX-mF CATGATATGTTTTATGCTGAACGG +49 to +72 Forward
The positions of the primers are relative to the start codon of the mouse Col10a1 or the thyA genes. The sequences in bold letters are overhang regions. In primers
ColX-thyAF and ColX-thyAR, Col10a1 sequences are in bold letters and thyA sequences are in italics. The sequences that are in both bold and italics in primers
ColX-mF and ColX-mR represent the codon to be mutated in the mouse Col10a1 gene. Sequence assignment numbers for the collagen X primers are taken from
Kong et al. (27) and for thyA from Belfort et al. (28).
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recombination system was activated (42C) prior to electro-
poration as compared with only two colonies without prior
activation (maintained at 32C) (Table 2). Twelve colonies
were selected for analysis; deletion of the thyA gene from the
bacterial genome was confirmed by PCR amplification using
primers flanking the thyA gene in eleven of the twelve colonies
(Table 2 and Figure 1B). One colony with the correct recomb-
ination was selected as the newly generated thyA-null strain
(QW1), where sequencing of the PCR product confirmed the
expected deletion in the gene (data not shown).
Establishment and confirmation of selective growth
conditions
To establish that QW1 can be utilized to facilitate the selection
of homologous recombination events between exogenous
DNAs, a number of ‘rescue’ assays were performed to test the
newly designed thyA selection system. The introduction of a
full-length functional thyA gene in a plasmid (pThyA-FL)
restored ‘normal’ cell function in QW1. Under the appropriate
growth selection for the presence of ThyA function, >1300
colonies were observed (Table 2). A similar result was
obtained for the introduction of plasmid pThyA-D30
(Table 2), indicating that DNA sequence encoded in thyA
D30 is also fully functional. The use of thyAD30 is preferred
for subsequent mutagenesis experiments as it lacks 347 bp 30
to the terminator of the thyA gene, minimizing potential
recombination events where the thyA gene may recombine
back into the original position in the bacterial chromosome,
introducing false positives. Furthermore, we have shown that
transformation of linear PCR DNA fragments, thyA-FL or
thyAD30 (Figure 2A), did not result in ThyA function, indicating
that during the selective growth period, the linear DNAs are
likely to be degraded and will not contribute to false positives.
This is supported by the very low frequency or absence of
colonies in transformation of QW1 with thyA-FL or thyAD30
PCR-amplified DNA fragments when the l-Red recombina-
tion system is not active (Table 2).
Site-directed mutagenesis of the mouse Col10a1 gene
As a proof of principle experiment, we utilized the ThyA
selection system in QW1 to introduce a specific 2 bp mutation
in a plasmid containing the mouse Col10a1 gene relying solely
on the l-Red recombination system. The overall strategy is
illustrated in Figure 3A. It involves two rounds of homologous
recombination in QW1. The first round is between a plasmid
containing the normal Col10a1 sequence (pKM2-ColX) and a
PCR-generated DNA fragment containing DthyA sequence
flanked by 50 bp of Col10a1 sequences, corresponding to
the 50 and 30 regions of the intended site of mutagenesis,
respectively. When the l-Red recombination system is activ-
ated, the 50 bp flanking sequences of homology to normal
Col10a1 sequence are sufficient to allow homologous recomb-
ination in QW1 to promote the incorporation of the DthyA
gene into pKM2-ColX, with an efficiency of 1.32 · 104 recom-
binants/mg DNA when growth was selected in conditional
medium lacking thymine (Table 2). Of the 13 colonies selec-
ted, 1 colony showed only the parental plasmid, while
12 colonies showed a varying mixture (1:2) of parental
and correctly recombined plasmids by PCR amplification
of the region corresponding to the site of DthyA integration.
Colonies containing only the recombinant plasmid were
obtained by retransformation in QW1 and selected for
ThyA function. A representation of the respective PCR prod-
uct with (1565 bp) and without (530 bp) DthyA integration is
shown in Figure 3B.
With DthyA integrated, the strategy is to remove it in a
second recombination event whereby the desired 2 bp sub-
stitution mutation is introduced into the plasmid. The base
Bacterial chromosome
DY380
thyA
∆thyA (PCR product)
thyA-null
strain
Bacterial chromosome
thyA
Bacterial chromosome
∆thyA
QW1
thyA+
strain
λ-Red induced
recombination
A
B
R1F1
R1F1
M 1 2 3 4 5
1470 bp
744 bp
4000
1650
(bp)
1000
650
Figure 1. Generation of a thyA-null bacterial strain (QW1). (A) Schematic
representation of the strategy to inactivate the endogenous thyA gene in DY380.
The thyA gene is deleted through homologous recombination between the
endogenous gene and a DNA fragment DthyA generated by PCR (see
Materials and Methods for details). This process is assisted by the l-Red
recombination system present in DY380. (B) Genotype analysis of the
resultant colonies following appropriate growth selection for the absence of
ThyA function. The DNA products after PCR amplification of chromosomal
DNA with primers F1 and R1 flanking the thyA gene were analyzed by 1% (w/v)
agarose gel electrophoresis stained with ethidium bromide. Lanes 2–5 are PCR
products (744 bp) from four representative thyA-null colonies; lane 1 is the 1470
bp PCR product from the parental strain DY380; M is a DNA molecular size
marker (Invitrogen).
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changes were first introduced into a PCR product (ColX-
G18D) containing Col10a1 sequence by overlapping PCR
as shown schematically in Figure 2B. Through homologous
recombination of this PCR with pKM2-ColX-DthyA, the
DthyA integration was removed and the 2 bp substitution
introduced precisely. When selected in culture conditions
for cells without ThyA function, we obtained on average
>1200 colonies (Table 2) when the l-Red recombination sys-
tem was activated. Of the 16 colonies selected, 14 showed the
correct recombination event confirmed by PCR amplification
of the region containing the 2 bp substitution with only trace
amounts of parental plasmids. Thus, this indicates that the
recombination can be very efficient as previously reported
(8), and that the counter selection process is sufficient to dif-
ferentiate growth of cells with significant differences in the
level of ThyA function. Furthermore, there will be a selection
pressure for the enrichment of progenies with reducing ThyA
function through random segregation.
Because the base pair changes also introduced a new BspHI
restriction enzyme site, the presence of the mutation was mon-
itored by BspHI digestion of the PCR product (Figure 3C), and
confirmed by DNA sequencing of the plasmids isolated from
the appropriate clones (Figure 3D). Together with the data
from the generation of the thyA-null strain (QW1), this
shows that the selectivity of the system is extremely high
with 90% of the colonies exhibiting the expected phenotype
with respect to ThyA function.
To demonstrate that the ThyA recombineering system can
be applied to BACs, we performed mutagenesis in a 317 kb
BAC (RP23-194I3) containing the mouse Col10a1 gene.
Compared with plasmid DNA, the total number of colonies
was lower for BACs, in the order of 5–10, 10–20 and 30–40
colonies using 2, 4 and 8 mg of PCR product for transforma-
tion, respectively. However, the selection efficiency remained
high with >90% of the colonies contained the appropriate
recombination event for the insertion of thyA into the BAC
(9 from 9 colonies selected), or its subsequent removal (9 from
10 colonies selected). Introduction of thyA into the BAC was
monitored by PCR as described above (data not shown), and
confirmed by Southern blot analysis (Figure 4A). The DNA
sequence of a final modified BAC (FColX-BAC-G18D) con-
taining the G18D mutation with the Flag1 sequence in exon 2
is shown in Figure 4B.
DISCUSSION
With the completion of many genome projects, the next step is
to understand the function and regulation of genes that are
discovered. Functional genomics will play a major role. There
is a need for the ability to manipulate DNA for expression
studies, to create targeting vectors for making transgenic
organisms and to investigate the regulation of gene expression
and gene function through site-specific mutagenesis.
Recently, the development of recombineering procedures
utilizing homologous recombination in bacteria has allowed
DNA manipulation without the need for restriction enzymes,
large plasmid DNA fragments or vectors carrying large DNA
inserts, such as BACs, P1-derived or yeast artificial chromo-
somes. However, the efficiency is generally low and recover-
ing the appropriate clones requires the screening of hundreds
to thousands of colonies, or having to engineer a gene for
growth selection, such as an antibiotic gene (22,23). Further-
more, some approaches retain unwanted residual DNA
sequences that may interfere with gene function or are limited
to a single manipulation. Here, we have developed a unique
selection system in E.coli to enhance the usefulness and effi-
ciency of the recombineering technique, utilizing a positive–
negative selection system based on a single marker, the thyA
gene, allowing seamless multiple manipulations of DNA.
With the thyA selection system, as a proof of principle
experiment, we have successfully created a 2 bp mutation
in exon 2 of the mouse collagen X gene, Col10a1. Overall,
this system showed an average selection efficiency of >90%,
requiring the screening of fewer than 10 colonies to ensure a
successful outcome. This is a valuable improvement of the
bacteriophage l-Red recombination system, with advantages
over existing systems. Its greatest advantage is that the selec-
tion of clones with or without ThyA function is based on growth
of the bacteria concerned, with minimal background ranging
from 0.01 to 0.08%.
Under optimal conditions, the efficiency of the bacterio-
phage l-Red recombination system without selection has
been reported at best to be only 0.1% (5) and 0.17% (10)
of surviving cells. Therefore, although this is a single step
without further manipulations, more than 1000 colonies
need to be screened to obtain one or two recombinants.
With appropriate selection using the ThyA system, we have
obtained 14 recombinants from 16 colonies.
Table 2. Summary of the thyA-null experiment, rescue assays, first and second stages of Col10a1 mutagenesis
Experiment Bacterial strain and DNA
fragment/plasmid used
Induction of
l-Red
system
Total
number of
colonies
No. of correctly targeted
colonies relative to the
number of colonies screened
Selection
efficiency
(%)
thyA-null strain (QW1) DY380 + DthyA (PCR) + 255 11 out of 12 92
DY380 + DthyA (PCR)  2 0 out of 2 —
Rescue assays QW1 + pThyA-FL  1346 — —
QW1 + pThyAD30  1386 — —
QW1 + thyA-FL (PCR)  0 — —
QW1 + thyA-D30 (PCR)  0 — —
First stage of Col10a1 mutagenesis QW1-pKM2-ColX + X-thyAD30-X0 (PCR) + 2500 12 out of 13 96
 1 0 out of 1 —
Second stage of Col10a1 mutagenesis QW1-(X-thyAD30-X0) + ColX-G10D (PCR) + 1260 14 out of 16 94
 1 0 out of 1 —
The values given are the result from a typical experiment, while the selection efficiency percentage is the mean of three independent experiments. PCR denotes DNA
fragments generated by PCR.
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Our system is superior to similar ones that positively select
for growth of the desired recombinants, such as the use of a
selection cassette containing the EcoRI endonuclease and an
antibiotic gene that allows selection of the desired clone at an
efficiency of only 0.35% (2 recombinants from 570 colonies)
(24). In this system, expression of EcoRI endonuclease,
which is toxic to cells in the absence of the corresponding
methylase, is induced by the addition of isopropyl-b-d-
thiogalactopyranoside to kill unwanted clones. Despite the
high killing efficiency of EcoRI endonuclease, there is
still a high background with >95% false-positive clones.
The same group, wanting to improve the efficiency, altered
the selection cassette to contain a rarer cutter, I-SceI endo-
nuclease, and an antibiotic gene. However, the efficiency was
A
B
1470 bp
1124 bp
744 bp
1224 bp
thyA-FL 
thyA∆3’
∆thyA
X-thyA∆3’-X’
Promoter
Factor Sigma 54 binding site Translation stop
Terminator
5’
5’
5’
5’
3’
3’
3’
3’
∆
ATG
GGG
CCC
…..
…..
…..
…..
CTA
GAT
5’ 3’
Exon 2
Col10a1
Overlapping PCR
ColX-G18D
ColX-F
ColX-RColX-mF
ColX-mR
ColX-F
ColX-R
C
5’ 3’
Exon 2
Col10a1 (pG18D-Flag)
FColX-G18D
ColX-F ColX-R
… GTG CAC GAC …
PCR
Flag
Figure 2. Schematic representation of the PCR DNA fragments ThyA-F, ThyA-D30, DThyA and X-thyAD30-X0. (A) PCR amplification using primers thyA-F1
and thyA-R1 (Table 1) amplifies a 1470 bp fragment (thyA-FL) of the thyA gene containing the promoter, Factor Sigma 54 binding site and the transcription
termination flanking the start and stop codons for translation. The 1124 bp product, thyA-D30, amplified using primers thyA-F1 and thyA-R3 (Table 1), lacks 347 bp 30
of the transcription terminator. DthyA is a 744 bp product generated by overlapping PCR (see Materials and Methods for details) with most of the coding sequence
deleted (+123 to +848; relative to the translational start site), and D in the diagram represents the deleted region. X-thyAD30-X0 is a fusion product amplified using
primers ColX-thyAF and ColX-thyAR with 50 and 30 overhang sequences for the regions of the Col10a1 gene for homologous recombination. (B) Schematic
representation of the strategy for the generation of the ColX-G18D fragment. Two PCR products were first generated using primer sets, ColX-F/ColX-mR and
ColX-mF/ColX-R. These products, containing complementary sequences from primers ColX-mF and ColX-mR, were used in an overlapping PCR to produce
ColX-G18G using primers ColX-F and ColX-R. (C) Schematic representation for the amplification of a PCR product from a plasmid, pG18D-Flag, using primers
ColX-F and ColX-R. pG18D-Flag contains mutations (bold and underlined) around the signal peptide cleavage site of collagen X, and a Flag1 sequence inserted at
the 30 region of exon 2 (shaded region).
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Figure 3. Mutagenesis of the mouse collagen X gene (Col10a1) using QW1. (A) A schematic presentation of selective growth for thyA gene replacement and removal
through two rounds of homologous recombination events to introduce a 2 bp substitution in exon 2 of Col10a1. pKM2-ColX is a plasmid containing the normal
Col10a1 gene with GGG as the codon for Gly18. pKM2-ColX was first transformed into a thyA-null strain (QW1). This was followed by a second transformation with
a PCR product (X-thyAD30-X0) containing flanking sequences homologous to the Col10a1 gene (shaded region). Through homologous recombination, a specific
region of the Col10a1 gene in pKM2-ColX is replaced with thyA and this event is selected for by growth in defined medium (see Materials and Methods for details)
that requires ThyA function. A selected colony is then transformed with a PCR product containing Col10a1 sequence with a 2 bp mutation at codon 18 (GGG to GAT),
representing a G18D amino acid substitution. Activation of homologous recombination will remove the thyAD30 sequence and introduce the G18D mutation to
produce plasmid pFColX-G18D; growth conditions are used that select for the absence of ThyA function. (B) Confirmation of thyAD30 integration in pKM2-ColX
following the first round of homologous recombination. Colonies derived from growth selection for the reintroduction of ThyA function in QW1 were analyzed by
PCR amplification of the resultant plasmid using primers ColX-F and ColX-R (Table 1). Lanes 1 and 2 show the amplification products from pKM2-ColX (530 bp)
and pKM2-ColX-ThyA (1565 bp), respectively. M is a DNA molecular size marker (1 kb GeneRuler, MBI Fermentas). (C) Confirmation of thyAD30 removal and
introduction of a 2 bp substitution in pKM2-ColX following the second round of homologous recombination. The 2 bp substitution mutation introduces a new BspH1
restriction enzyme site in the 530 bp PCR product and will result in two fragments of 271 and 259 bp following digestion. M is a DNA molecular size marker (100 bp
GeneRuler, MBI Fermentas)); lanes 1 and 2 are the PCR fragments from pKM2-ColX and pColX-G18D digested with BspH1, respectively. (D) DNA sequencing
of pFColX-G18D showing that the codon GGG (glycine) has been specifically changed to GAT (aspartate) following the two rounds of homologous recombination
using the thyA selection system.
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improved to only 7.5% (7 recombinants from 93 colonies)
upon counter selection (25).
Other recent counter-selection strategies for BAC modi-
fications use the fused sacB/Neo gene (26) and the rspL
gene (18). However, these are negative selection systems
that suffer from a high background owing to mutational
events affecting the SacB protein (26) or rearrange-
ments (18).
Apart from counter-selection systems, selective procedures
like the use of antibiotics and site-specific recombinases, such
as Cre, and restriction enzyme digestion are also methods for
eliminating selection markers (3,10,26). However, these pro-
tocols create an end product that is not ‘clean’ in that there
remains a marker or a tag within the final product. These tags
may be problematic, causing unpredicted splicing, altered
binding of transcription factors or affecting regulation of
gene expression at distant sites that cannot be predicted
from sequence analysis alone.
By combining the advantages of the l-Red recombination
and the selection of ThyA function in E.coli, we have
developed a system that has high and accurate efficiency in
the selection of a well-proven homologous recombination
event induced by specific genes of the l-prophage. This sys-
tem should be applicable to plasmids, P1-derived artificial
chromosomes or bacterial artificial chromosomes. In theory,
this system can allow unlimited seamless modifications in
different regions of the vectors or chromosomes concerned.
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